Genovate Biotechnology Co., Ltd. produces and markets antimicrobial agents, antineoplastic agents, cardiovascular system drugs, digestive system drugs, external agents, nervous system drugs, non-addictive analgesics and anti-inflammatory drugs, urinary system drugs, and vitamins.

Announcement Of The Change Of The Internal Audit Officer

The Company Was Invited By Masterlink Securities
To Participate The Investors' Conference.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Genovate Biotechnology Co (4130 TT)

Announcement Of The Change Of The Internal Audit Officer

The Company Was Invited By Masterlink Securities To Participate The Investors' Conference.

Board Of Directors Approved The Company'S Consolidated Financial Report Of Q3, 2024.

Announcement Of The Expiration Period And Implementation Status Of The Company'S Repurchase Of Treasury Shares.

Announcement For The Bod Meeting Date Of 2024q3 Financial Report.

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)